Trial intelligence / Profile preview

Botox vs Occlusal Splint for Facial Muscular Pain

NCT03456154Phase 4Completed

Sponsor
Universidade Federal de Pelotas
Start
Mar 2018
Primary completion
Jan 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in myofascial pain syndrome (MPS), sponsored by Universidade Federal de Pelotas. Started Mar 2018; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

myofascial pain syndrome (MPS)

Beyond the preview

Go deeper on NCT03456154.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03456154.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call